The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 20, 2009

Filed:

Dec. 13, 2004
Applicants:

Vincent J. Colandrea, North Brunswick, NJ (US);

George A. Doherty, Superior, CO (US);

Jeffrey J. Hale, Westfield, NJ (US);

Pei Huo, Millburn, NJ (US);

Irene E. Legiec, Mountainside, NJ (US);

Leslie Toth, Woodbridge, NJ (US);

Petr Vachal, Summit, NJ (US);

Lin Yan, East Brunswick, NJ (US);

Inventors:

Vincent J. Colandrea, North Brunswick, NJ (US);

George A. Doherty, Superior, CO (US);

Jeffrey J. Hale, Westfield, NJ (US);

Pei Huo, Millburn, NJ (US);

Irene E. Legiec, Mountainside, NJ (US);

Leslie Toth, Woodbridge, NJ (US);

Petr Vachal, Summit, NJ (US);

Lin Yan, East Brunswick, NJ (US);

Assignee:

Merck & Co., Inc., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/443 (2006.01); A61K 31/4245 (2006.01); C07D 413/04 (2006.01); C07D 271/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention encompasses compounds of Formula I: as well as the pharmaceutically acceptable salts thereof. The compounds are S1P/Edg1 receptor agonists and thus have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity. The invention is also directed to pharmaceutical compositions containing such compounds and methods of treatment or prevention.


Find Patent Forward Citations

Loading…